Share: Analysts expect a more than 114% gain in share price, $25 million in 2021 revenues, and YOY gains of roughly 415% SANUWAVE Health (OTC: SNWV) is showing that its transformational acquisition of Celularity’s UltraMIST ultrasound healing therapy is paying off. The company just posted a blowout third quarter with revenues surging by more than 895% compared to the same quarter last year. Better still, with its more than 100 person sales force penetrating new markets, revenues are expected to reach $3 million in this quarter, helping to push a more than 415% gain in year-over-year revenues. And revenues beyond 2020 are expected to surge. Analysts covering the stock expect a massive increase in revenues during 2021. In fact, their models project another round of record revenues with a climb to $25 million in next year’s revenues. If their models are correct, it will deliver yet another consecutive triple-digit gain to its yearly run-rate.